Neurology - Continuous subcutaneous foslevodopa/foscarbidopa infusion shows promise in phase 3 study

Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson's disease, according to data...